Similar articles

• Controlled intralesional deposition of a sclerotic in verruca therapy.

  Locke RK, Zang K. Locke RK, et al. J Am Podiatry Assoc. 1969 Oct;59(10):377-84. doi: 10.7547/87507315-59-10-377. J Am Podiatry Assoc. 1969. PMID: 5350157 Clinical Trial. No abstract available.
• Verruca plantaris: a compendium of its understanding and treatment.

  Luciano CS. Luciano CS. J Am Podiatry Assoc. 1977 Dec;67(12):858-69. doi: 10.7547/87507315-67-12-858. J Am Podiatry Assoc. 1977. PMID: 925320 No abstract available.
• Intralesional cidofovir for the treatment of a plantar wart.

  Moore E, Kovarik C. Moore E, et al. J Am Acad Dermatol. 2015 Jul;73(1):e23-4. doi: 10.1016/j.jaad.2015.02.1143. J Am Acad Dermatol. 2015. PMID: 26089066 No abstract available.
• Flagellate hyperpigmentation following intralesional bleomycin treatment of verruca plantaris.

  Abess A, Keel DM, Graham BS. Abess A, et al. Arch Dermatol. 2003 Mar;139(3):337-9. doi: 10.1001/archderm.139.3.337. Arch Dermatol. 2003. PMID: 12622626 Review.
• Lymphangitis as a complication of intralesional bleomycin therapy.

  Allen AL, Fosko SW. Allen AL, et al. J Am Acad Dermatol. 1998 Aug;39(2 Pt 1):295-7. doi: 10.1016/s0190-9622(98)70097-0. J Am Acad Dermatol. 1998. PMID: 9704855 Review. No abstract available.